Silk fibroin (SF) scaffolds have emerged as a promising candidate for bone regeneration, offering a viable alternative to autografts and allografts, which are often limited by various factors. SF scaffolds stand out due to their exceptional biocompatibility, mechanical properties, biodegradability, and structural adjustability. These properties, combined with well-designed structures and surface modifications, make SF scaffolds highly attractive for bone regeneration applications. However, despite the evident potential of SF scaffolds, there is still a need for comprehensive efforts to enhance their clinical translation, including further experimentation in large animal models and clinical trials. Moreover, deeper investigations are necessary to elucidate the degradation mechanisms of SF scaffolds and evaluate the impact of their degradation products.
Key Points:
– SF scaffolds offer a promising solution for bone regeneration, surpassing the limitations of autografts and allografts.
– The unique properties of SF, such as biocompatibility and mechanical strength, make it an ideal candidate for bone scaffolds.
– Further research is essential to optimize the clinical translation of SF scaffolds and understand their long-term implications, including degradation mechanisms.
Tags: regenerative medicine, bioprinting, regulatory, secretion, sterilization, clinical trials, freeze drying
Read more on pmc.ncbi.nlm.nih.gov